Insmed (NASDAQ:INSM) just reported results for the second quarter of 2024.
- Insmed reported earnings per share of -$1.94. This was below the analyst estimate for EPS of -$1.27.
- The company reported revenue of $90.34 million.
- This was 2.72% better than the analyst estimate for revenue of $87.95 million.